236 related articles for article (PubMed ID: 22915767)
1. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
Jirkovsky E; Popelová O; Kriváková-Stanková P; Vávrová A; Hroch M; Hasková P; Brcáková-Dolezelová E; Micuda S; Adamcová M; Simůnek T; Cervinková Z; Gersl V; Sterba M
J Pharmacol Exp Ther; 2012 Nov; 343(2):468-78. PubMed ID: 22915767
[TBL] [Abstract][Full Text] [Related]
2. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M
Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762
[TBL] [Abstract][Full Text] [Related]
3. Proteomic insights into chronic anthracycline cardiotoxicity.
Stěrba M; Popelová O; Lenčo J; Fučíková A; Brčáková E; Mazurová Y; Jirkovský E; Simůnek T; Adamcová M; Mičuda S; Stulík J; Geršl V
J Mol Cell Cardiol; 2011 May; 50(5):849-62. PubMed ID: 21284945
[TBL] [Abstract][Full Text] [Related]
4. Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up.
Lenčová-Popelová O; Jirkovský E; Mazurová Y; Lenčo J; Adamcová M; Šimůnek T; Geršl V; Štěrba M
PLoS One; 2014; 9(5):e96055. PubMed ID: 24804796
[TBL] [Abstract][Full Text] [Related]
5. Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
Lenčová-Popelová O; Jansová H; Jirkovský E; Bureš J; Jirkovská-Vávrová A; Mazurová Y; Reimerová P; Vostatková L; Adamcová M; Hroch M; Pokorná Z; Kovaříková P; Šimůnek T; Štěrba M
Toxicology; 2016 Nov; 372():52-63. PubMed ID: 27816693
[TBL] [Abstract][Full Text] [Related]
6. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.
Dziegiel P; Jethon Z; Suder E; Sopel M; Rabczyński J; Surowiak P; Zabel M
Exp Toxicol Pathol; 2002 Feb; 53(6):433-9. PubMed ID: 11926284
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity.
Sterba M; Popelová O; Simunek T; Mazurová Y; Potácová A; Adamcová M; Kaiserová H; Ponka P; Gersl V
J Pharmacol Exp Ther; 2006 Dec; 319(3):1336-47. PubMed ID: 17003229
[TBL] [Abstract][Full Text] [Related]
8. Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo.
Popelová O; Sterba M; Simůnek T; Mazurová Y; Guncová I; Hroch M; Adamcová M; Gersl V
J Pharmacol Exp Ther; 2008 Jul; 326(1):259-69. PubMed ID: 18434588
[TBL] [Abstract][Full Text] [Related]
9. Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats.
Gounder VK; Arumugam S; Arozal W; Thandavarayan RA; Pitchaimani V; Harima M; Suzuki K; Nomoto M; Watanabe K
Int Immunopharmacol; 2014 Feb; 18(2):282-9. PubMed ID: 24291173
[TBL] [Abstract][Full Text] [Related]
10. Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice.
Sahu BD; Kumar JM; Kuncha M; Borkar RM; Srinivas R; Sistla R
Life Sci; 2016 Jan; 144():8-18. PubMed ID: 26606860
[TBL] [Abstract][Full Text] [Related]
11. New iron chelators in anthracycline-induced cardiotoxicity.
Kaiserová H; Simunek T; Sterba M; den Hartog GJ; Schröterová L; Popelová O; Gersl V; Kvasnicková E; Bast A
Cardiovasc Toxicol; 2007; 7(2):145-50. PubMed ID: 17652820
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart.
Montaigne D; Marechal X; Baccouch R; Modine T; Preau S; Zannis K; Marchetti P; Lancel S; Neviere R
Toxicol Appl Pharmacol; 2010 May; 244(3):300-7. PubMed ID: 20096298
[TBL] [Abstract][Full Text] [Related]
13. Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value.
Adamcova M; Lencova-Popelova O; Jirkovsky E; Mazurova Y; Palicka V; Simko F; Gersl V; Sterba M
Int J Cardiol; 2015 Dec; 201():358-67. PubMed ID: 26310978
[TBL] [Abstract][Full Text] [Related]
14. Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart.
de Nigris F; Rienzo M; Schiano C; Fiorito C; Casamassimi A; Napoli C
Eur J Cancer; 2008 Feb; 44(3):334-40. PubMed ID: 18194856
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cellular mechanisms of anthracycline cardiotoxicity.
Chen B; Peng X; Pentassuglia L; Lim CC; Sawyer DB
Cardiovasc Toxicol; 2007; 7(2):114-21. PubMed ID: 17652815
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats.
Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
Toxicology; 2010; 274(1-3):18-26. PubMed ID: 20452391
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity.
Vávrová A; Popelová O; Stěrba M; Jirkovský E; Hašková P; Mertlíková-Kaiserová H; Geršl V; Simůnek T
Arch Toxicol; 2011 May; 85(5):525-35. PubMed ID: 21046361
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics.
Marechal X; Montaigne D; Marciniak C; Marchetti P; Hassoun SM; Beauvillain JC; Lancel S; Neviere R
Clin Sci (Lond); 2011 Nov; 121(9):405-13. PubMed ID: 21605084
[TBL] [Abstract][Full Text] [Related]
19. Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats.
Thompson KL; Rosenzweig BA; Zhang J; Knapton AD; Honchel R; Lipshultz SE; Retief J; Sistare FD; Herman EH
Cancer Chemother Pharmacol; 2010 Jul; 66(2):303-14. PubMed ID: 19915844
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
Jaenke RS; Deprez-DeCampeneere D; Trouet A
Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
